Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 11-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,122 | 10,350 | 12,162 | 14,047 | N/A |
| Marketable Securities | 7,211 | 11,162 | 11,951 | 10,794 | N/A |
| Other current assets | 2,123 | 1,999 | 0 | 0 | 0 |
| TOTAL | $22,282 | $24,589 | $24,609 | $25,355 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 1,519 | 1,524 | 0 |
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 0 |
| Other Non-Current Assets | 84 | 76 | 84 | 86 | 0 |
| TOTAL | $2,123 | $2,115 | $3,642 | $3,649 | $N/A |
| Total Assets | $24,405 | $26,704 | $28,251 | $29,004 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 482 | 843 | 996 | 628 | 0 |
| TOTAL | $527 | $875 | $1,027 | $659 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40 | 49 | 57 | 59 | 0 |
| TOTAL | $40 | $49 | $57 | $59 | $N/A |
| Total Liabilities | $567 | $924 | $1,084 | $718 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 158 | 157 | N/A | 157 | N/A |
| Common Shares | 42 | 42 | 3 | 42 | N/A |
| Retained earnings | -25,352 | -22,903 | -20,938 | -19,451 | N/A |
| Other shareholders' equity | -176 | -64 | -18 | -23 | 0 |
| TOTAL | $23,838 | $25,780 | $27,167 | $28,286 | $N/A |
| Total Liabilities And Equity | $24,405 | $26,704 | $28,251 | $29,004 | $0 |